|
NASP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70690000000917E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.778200E-04 |
| Normal-vs-Stage2 |
3.85769999999841E-05 |
| Normal-vs-Stage3 |
5.37180000481641E-08 |
| Normal-vs-Stage4 |
9.5135000000024E-07 |
| Stage1-vs-Stage2 |
7.262000E-02 |
| Stage1-vs-Stage3 |
1.283950E-03 |
| Stage1-vs-Stage4 |
5.123100E-03 |
| Stage2-vs-Stage3 |
5.726000E-01 |
| Stage2-vs-Stage4 |
4.247200E-01 |
| Stage3-vs-Stage4 |
7.161800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81940000002034E-06 |
| Normal-vs-AfricanAmerican |
2.877300E-03 |
| Normal-vs-Asian |
6.069700E-02 |
| Caucasian-vs-AfricanAmerican |
8.608200E-01 |
| Caucasian-vs-Asian |
3.463600E-02 |
| AfricanAmerican-vs-Asian |
1.078390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.036700E-04 |
| Normal-vs-Female |
8.80049999985033E-07 |
| Male-vs-Female |
4.488600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.577400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.41140000020634E-07 |
| Normal-vs-Age(61-80Yrs) |
9.08160000534508E-08 |
| Normal-vs-Age(81-100Yrs) |
1.015700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.564530E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.43989999999928E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.578600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.262000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.341800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.732000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.079170E-03 |
| Classical-VS-Follicular |
2.214300E-02 |
| Classical-VS-Other |
9.055400E-01 |
| Classical-VS-Normal |
1.204510E-04 |
| Tall-VS-Follicular |
2.400200E-01 |
| Tall-VS-Other |
1.035350E-01 |
| Tall-VS-Normal |
5.65280000031088E-07 |
| Follicular-VS-Other |
4.285800E-01 |
| Follicular-VS-Normal |
3.61829999999674E-05 |
| Other-VS-Normal |
2.080200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.48979999997834E-06 |
| Normal-vs-N1 |
3.829500E-04 |
| N0-vs-N1 |
8.415200E-01 |
|
|
